Amgen and Novartis tussle over biosimilar injunction
June 4, 2015Sales and Marketing Amgen, FDA, Neupogen, Novartis
Novartis has begun its court battle with Amgen over its biosimilar of cancer drug Neupogen, which Amgen is trying to …
FDA to assess female libido drug
June 4, 2015Sales and Marketing FDA, Sprout Pharmaceutical, flibanserin, libido
The FDA is inching closer to a historic approval of a drug in the US commonly dubbed ‘Viagra for women’. …
Astellas spending $760m on autoimmune tie-up
June 4, 2015Sales and Marketing Astellas, anokion, brett wells, kanyos
Astellas Pharma and Anokion are to collaborate and develop new treatments for type 1 diabetes and celiac disease in a deal that could net …
Creabilis appoints board chairman
June 4, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Catherine Moukheibiras, creabilis
UK, Canterbury-based dermatology firm Creabilis has appointed Catherine Moukheibiras as the chairman of its board of directors. After an initial career in strategy …
Featured Interview on Industrial Design of Auto Injectors
June 4, 2015Sales and Marketing auto injectors, ondrugdelivery, shl group
The necessity for auto injector has been growing rapidly over the years, spurring a variety of innovative designs to meet …
Shire earns EMA nod for constipation drug
June 3, 2015Sales and Marketing EMA, Resolor, Shire, constipation
Shire has seen approval from the European Medicines Agency to extend the licence of its constipation drug Resolor for men …
Merck tests new Keytruda combination
June 3, 2015Research and Development, Sales and Marketing Merck, dynavax, keytruda
Merck is continuing to investigate Keytruda combinations as it signs a deal to test the drug with an immunotherapy from …
Perrigo buys OTC products from GSK
June 3, 2015Sales and Marketing GSK, GlaxoSmithKline, Mylan, Perrigo, Teva, brett wells
In an all-cash move with no financial details disclosed Perrigo is buying a portfolio of leading over-the-counter products from GlaxoSmithKline. …
Clark Health Communications hires three
June 3, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Clark Health Communications
Clark Health Communications (CHC) has announced the hire of three new team members. The UK, London-based firm has recently welcomed …
NICE: people should be more involved in medical decisions
June 2, 2015Sales and Marketing NHS, NICE, medicines, optimisation
Around 15 million people in England now have at least one long-term condition, but figures suggest that as many as …
Bayer and Gilead expand in manufacturing
June 2, 2015Manufacturing and Production, Sales and Marketing Bayer, Gilead, brett wells, manufacturing
Both Bayer and Gilead are investing heavily into their manufacturing operations with expansion plans being laid down in Indonesia and …
NICE signs-off Roche’s Gazyvaro for leukaemia
June 2, 2015Sales and Marketing Allergan, Bayer, CLL, Carole Longson, Eylea, Gazyvaro, NICE, Ozurdex, Roche, diabetic macular edema, leukaemia
NICE has given positive final guidance backing the use of Roche’s Gazyvaro for people with chronic lymphocytic leukaemia (CLL). Earlier …
Mylan tells Teva to ‘stop playing games’ and make firm bid
June 2, 2015Manufacturing and Production, Sales and Marketing M&A, MA, Mylan, Teva, generics
Mylan has written another strongly-worded letter to Teva, this time accusing the Israeli firm of ‘playing games’ and violating US …
Amgen hires head of Europe from Roche
June 2, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Corinne Le Goff, Roche
Corinne Le Goff is joining Amgen to be its senior vice president and head of the European region for the …
NICE Lynparza rejection labelled ‘hard to understand’
June 2, 2015Sales and Marketing AstraZeneca, NICE, lynparza, olaparib
AstraZeneca has appealed to the government to put ‘urgent transitional measures’ in place to make sure patients can access innovative …
AstraZeneca lung drug shines on
June 1, 2015Sales and Marketing ASCO, AZD9291, AstraZeneca, MEDI4736, NSCLC, Tafinlar
AstraZeneca’s investigational drug AZD9291 is continuing to impress, with results announced at cancer conference ASCO building on its previous ‘unprecedented’ …
BMS immunotherapy combination impresses at ASCO
June 1, 2015Research and Development, Sales and Marketing ASCO, BMS, Yervoy, opdivo
Bristol-Myers Squibb has presented data showing that a combination of its immunotherapies Opdivo and Yervoy significantly increases survival in advanced …
Pfizer breast cancer drug delivers
June 1, 2015Sales and Marketing ASCO, AZ, Faslodex, Pfizer, breast cancer, brett wells
A Phase III study on Pfizer’s treatment Ibrance in combination with hormone therapy has revealed the drug more than doubled …
Former GSK Oncology president joins Kesios
June 1, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Paolo Paoletti, kesios
The Imperial Innovations Group has confirmed the appointment of Dr Paolo Paoletti to be the executive chairman of Kesios Therapeutics.Paoletti …
Searching for new biotech solutions
June 1, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, Emily Drabant Conley, google
For pharma, the elevator pitch for 23andMe is an intriguing prospect. It has the largest genetic database in the world, …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
